Gretchen Bergado
Center of Molecular Immunology (Cuba)(CU)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Monoclonal and Polyclonal Antibodies Research, COVID-19 Clinical Research Studies, Glycosylation and Glycoproteins Research, HER2/EGFR in Cancer Research
Most-Cited Works
- → SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies(2021)88 cited
- → Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials(2022)38 cited
- → Bestatin and bacitracin inhibit porcine kidney cortex dipeptidyl peptidase IV activity and reduce human melanoma MeWo cell viability(2020)31 cited
- → A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicity(2022)31 cited
- → Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults(2022)30 cited
- → Sticholysin II-mediated cytotoxicity involves the activation of regulated intracellular responses that anticipates cell death(2018)22 cited
- → Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children(2022)21 cited
- → JM-20 treatment prevents neuronal damage and memory impairment induced by aluminum chloride in rats(2021)18 cited
- → Bufadienolides preferentially inhibit aminopeptidase N among mammalian metallo-aminopeptidases; relationship with effects on human melanoma MeWo cells(2022)16 cited